1. Kidney Injury and Repair Biomarkers in Marathon Runners
Sherry G. Mansour, DO, Gagan Verma, MPH, Rachel W. Pata, DPT, CCS, Thomas G. Martin, PhD, Mark A. Perazella, MD, Chirag R. Parikh, MD, PhD 
American Journal of Kidney Diseases 
Volume 70, Issue 2, Pages (August 2017)
DOI: /j.ajkd
Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Enrollment chart of runners in the study cohort. Abbreviation: NSAID, nonsteroidal anti-inflammatory drug.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

3. Figure 2
Absolute change in serum creatinine level per runner compared to baseline value on day 0.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

4. Figure 3
Representative urine microscopy images of samples from 4 runners by time point.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

5. Figure 4
Fold increase in biomarker levels compared to baseline on day 0. Abbreviations: IL-6, interleukin 6; IQR, interquartile range; KIM-1, kidney injury molecule 1; MCP-1, monocyte chemoattractant protein 1; NGAL, neutrophil gelatinase-associated lipocalin; TNF-α, tumor necrosis factor α; YKL-40, human cartilage glycoprotein 39.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

6. American Journal of Kidney Diseases 2017 70, 252-261DOI: (10. 1053/j
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions